Molecular characterisation of rifampicin-resistant <i>Mycobacterium tuberculosis</i> strains from Malawi

• Ngā kaituhi matua: Tarsizio Chikaonda (Author), Irene Ketseoglou (Author), Nelson Nguluwe (Author), Robert Krysiak (Author), Isaac Thengolose (Author), Felix Nyakwawa (Author), Nora E. Rosenberg (Author), Christopher Stanley (Author), James Mpunga (Author), Irving F. Hoffman (Author), Maria A. Papathanasopoulos (Author), Mina Hosseinipour (Author), Lesley Scott (Author), Wendy Stevens (Author)
• Hōputu: Pukapuka
• I whakaputaina: AOSIS, 2017-03-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Background: Availability and access to the detection of resistance to anti-tuberculosis drug sremains a significant challenge in Malawi due to limited diagnostic services. The Xpert® MTB/RIF can detect Mycobacterium tuberculosis and resistance to rifampicin in a single, rapid assay. Rifampicin-resis...